Drug-Disease Interactions Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Drug-Disease Interactions. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Drug-Disease Interactions Indian Medical PG Question 1: The choice of antihypertensive medication also depends upon the co-morbid illness of the patient, and all of the following recommendations have been made except:
- A. In hypertensive patients with gout, diuretics are the first-line treatment. (Correct Answer)
- B. In hypertensive patients with heart failure, ACE inhibitors may be preferred
- C. In hypertensive patients with migraine, beta blockers are an excellent choice
- D. In hypertensive patients with peripheral vascular disease, calcium channel blockers are recommended
Drug-Disease Interactions Explanation: ***In hypertensive patients with gout, diuretics are the first-line treatment.***
* This statement is incorrect because **diuretics**, particularly **thiazide diuretics**, can **elevate uric acid levels** and precipitate or worsen gout attacks.
* Therefore, they are generally **contraindicated or used with caution** in patients with gout, not recommended as first-line treatment.
*In hypertensive patients with heart failure, ACE inhibitors may be preferred*
* **ACE inhibitors** are a cornerstone of heart failure treatment due to their ability to **improve cardiac remodeling**, reduce mortality, and alleviate symptoms.
* They are often preferred for their **vasodilatory effects** and ability to prevent volume overload, which benefits patients with heart failure.
*In hypertensive patients with migraine, beta blockers are an excellent choice*
* **Beta-blockers**, such as propranolol, are effective in both **blood pressure control** and the **prophylaxis of migraines** [1].
* This makes them an excellent choice for a hypertensive patient who also suffers from migraines, offering a dual therapeutic benefit [1].
*In hypertensive patients with peripheral vascular disease, calcium channel blockers are recommended*
* **Calcium channel blockers (CCBs)**, especially dihydropyridines like amlodipine, are beneficial in peripheral vascular disease (PVD) due to their **vasodilatory effects**.
* They can **improve blood flow** to the extremities, which is crucial in PVD, without negatively impacting symptoms like claudication.
Drug-Disease Interactions Indian Medical PG Question 2: Which of the following agents requires the MOST caution when combined with spironolactone due to increased risk of hyperkalemia:
- A. ACE inhibitors (Correct Answer)
- B. Beta-blockers
- C. Amlodipine
- D. Chlorothiazide
Drug-Disease Interactions Explanation: ***ACE inhibitors*** - Spironolactone is a **potassium-sparing diuretic** that increases potassium levels by blocking aldosterone's effects in the collecting duct [1]. - **ACE inhibitors** also decrease aldosterone production [2], leading to reduced potassium excretion and a significant risk of **severe hyperkalemia** when combined with spironolactone [1, 2].*Beta-blockers* - While beta-blockers can cause a slight increase in plasma potassium by inhibiting cellular potassium uptake, this effect is generally modest and does not pose a major hyperkalemia risk when co-administered with spironolactone. - Their primary interaction concerns blood pressure and heart rate, not direct potassium handling.*Amlodipine* - Amlodipine is a **calcium channel blocker** that primarily causes vasodilation and does not significantly alter potassium balance. - Therefore, it does not substantially increase the risk of hyperkalemia when used concurrently with spironolactone.*Chlorothiazide* - Chlorothiazide is a **thiazide diuretic** that promotes potassium excretion, leading to a risk of hypokalemia. - When combined with spironolactone, a potassium-sparing diuretic, these agents can **partially offset each other's effects** on potassium balance, potentially reducing the risk of hyperkalemia compared to ACE inhibitors.
Drug-Disease Interactions Indian Medical PG Question 3: All of the following drugs require dose reduction in renal failure except?
- A. Doxycycline (Correct Answer)
- B. Vancomycin
- C. Gentamicin
- D. Acyclovir
Drug-Disease Interactions Explanation: ***Doxycycline***
- **Doxycycline** is primarily eliminated via the gastrointestinal tract (fecal excretion) and does NOT require dose adjustment in patients with **renal impairment**. [1]
- Its unique elimination pathway makes it a safe choice for treating infections in patients with **renal failure**.
- This is a key distinguishing feature among tetracyclines.
*Vancomycin*
- **Vancomycin** is predominantly eliminated by the kidneys (80-90% unchanged in urine).
- Accumulation in renal failure can lead to **ototoxicity** and **nephrotoxicity**.
- Dosage must be carefully adjusted based on **creatinine clearance** and therapeutic drug monitoring is essential.
*Gentamicin*
- **Gentamicin**, an aminoglycoside, is almost entirely excreted unchanged by the kidneys.
- Highly **nephrotoxic** and **ototoxic** with narrow therapeutic index.
- Dose reduction and extended dosing intervals are critical in **renal failure** to prevent drug accumulation and serious adverse effects. [3]
*Acyclovir*
- **Acyclovir** is primarily eliminated renally (60-90% excreted unchanged in urine).
- Requires significant **dose reduction in renal impairment** to prevent crystalluria and neurotoxicity. [2]
- Dosing adjustment based on creatinine clearance is mandatory to avoid adverse effects.
Drug-Disease Interactions Indian Medical PG Question 4: A patient presents with nephrotic syndrome and hypoalbuminemia. Protein binding of which drug is not affected?
- A. Valproate
- B. Morphine (Correct Answer)
- C. Diazepam
- D. Tolbutamide
Drug-Disease Interactions Explanation: ***Morphine***
- Morphine is a **low protein-bound drug** (<35%), meaning a significant portion circulates freely.
- Therefore, even with **reduced albumin levels** in nephrotic syndrome, the free fraction available for action is not significantly altered.
*Valproate*
- Valproate is **highly protein-bound** (90-95%), primarily to albumin.
- In conditions like nephrotic syndrome with **hypoalbuminemia**, a decreased binding capacity leads to a higher free drug fraction and increased pharmacological effect.
*Diazepam*
- Diazepam is also **highly protein-bound** (98%), mainly to albumin.
- Like other highly bound drugs, **hypoalbuminemia** in nephrotic syndrome would increase its free fraction, potentially leading to increased side effects.
*Tolbutamide*
- Tolbutamide is another drug with **high protein binding** (>90%), predominantly to albumin.
- Reduced albumin levels in nephrotic syndrome would result in a **higher free concentration** of tolbutamide, increasing its hypoglycemic effect and risk of adverse reactions.
Drug-Disease Interactions Indian Medical PG Question 5: A patient on warfarin has a high INR. Which drug likely caused this?
- A. Amiodarone (Correct Answer)
- B. Phenytoin
- C. Carbamazepine
- D. Rifampicin
Drug-Disease Interactions Explanation: ***Amiodarone***
- Amiodarone is a well-known inhibitor of **CYP2C9**, the primary enzyme responsible for the metabolism of **S-warfarin**, the more potent enantiomer of warfarin.
- Inhibition of warfarin metabolism leads to increased warfarin levels, thereby enhancing its anticoagulant effect and causing a **higher INR**.
*Phenytoin*
- Phenytoin is an **enzyme inducer**, primarily of **CYP2C9** and **CYP3A4**.
- Its interaction with warfarin typically leads to **decreased warfarin levels** and a **lower INR**, reducing the anticoagulant effect.
*Carbamazepine*
- Carbamazepine is a potent **enzyme inducer**, particularly of **CYP3A4** and **CYP2C9**.
- Like phenytoin, it generally leads to **increased warfarin metabolism** and a **reduced INR**, thereby decreasing its anticoagulant efficacy.
*Rifampicin*
- Rifampicin is a strong **inducer of hepatic cytochrome P450 enzymes**, especially **CYP3A4** and **CYP2C9**.
- Its co-administration with warfarin significantly **increases warfarin metabolism**, resulting in **lower warfarin concentrations** and a **decreased INR**.
Drug-Disease Interactions Indian Medical PG Question 6: Which of the following is the most appropriate initial antihypertensive treatment for an elderly patient with isolated systolic hypertension?
- A. Amlodipine (Correct Answer)
- B. Lisinopril
- C. Atenolol
- D. Losartan
Drug-Disease Interactions Explanation: Amlodipine
- **Calcium channel blockers (CCBs)**, especially dihydropyridines like amlodipine, are recommended as initial therapy for isolated systolic hypertension in the elderly due to their effectiveness in reducing elevated systolic pressure [2].
- They are well-tolerated and can reduce the risk of cardiovascular events in this population.
*Lisinopril*
- **ACE inhibitors** like lisinopril are effective antihypertensives but are generally not the first-line choice for isolated systolic hypertension, particularly in elderly patients where a decrease in diastolic pressure might be detrimental [1].
- They are associated with side effects such as **cough** and can cause **acute kidney injury**, which can be a concern in older adults [1].
Atenolol
- **Beta-blockers** like atenolol are generally not recommended as first-line therapy for isolated systolic hypertension due to their limited efficacy in lowering systolic blood pressure compared to other drug classes.
- They may also worsen certain conditions common in the elderly, such as **peripheral vascular disease** and **bronchospastic lung disease**.
*Losartan*
- **Angiotensin receptor blockers (ARBs)** like losartan are effective for hypertension but are not typically favored over CCBs or thiazide diuretics as initial monotherapy for isolated systolic hypertension in the elderly [1].
- They share similar side effects and contraindications with ACE inhibitors, including the risk of **renal dysfunction** [1].
Drug-Disease Interactions Indian Medical PG Question 7: Assertion: ACE inhibitors are contraindicated in bilateral renal artery stenosis. Reason: They cause acute kidney injury by reducing efferent arteriolar tone.
- A. A true R false
- B. Both A & R true, R explains A (Correct Answer)
- C. Both A & R true, R doesn't explain A
- D. A false R true
Drug-Disease Interactions Explanation: ***Correct: Both A & R true, R explains A***
- **Assertion is TRUE**: ACE inhibitors are absolutely contraindicated in bilateral renal artery stenosis due to risk of acute kidney injury
- **Reason is TRUE**: In bilateral renal artery stenosis, the kidneys depend on **angiotensin II** to maintain GFR by constricting the efferent arteriole
- **R explains A**: ACE inhibitors block angiotensin II production → **efferent arteriolar dilation** → drastically reduced GFR → **acute kidney injury (AKI)**
- This direct mechanistic link makes the reason a complete explanation of the assertion
*Incorrect: A true R false*
- While the assertion is true, the reason is also **true** (not false)
- ACE inhibitors do reduce efferent arteriolar tone by blocking angiotensin II
- This is the precise mechanism causing AKI in these patients
*Incorrect: Both A & R true, R doesn't explain A*
- Both statements are indeed true, but this option is incorrect because the reason **does explain** the assertion
- The mechanism (reduced efferent arteriolar tone → decreased GFR) directly explains why ACE inhibitors are contraindicated
- The causal relationship is clear and direct
*Incorrect: A false R true*
- The assertion is **true**, not false
- ACE inhibitors are definitively contraindicated in bilateral renal artery stenosis
- This is a well-established clinical contraindication to prevent renal failure
Drug-Disease Interactions Indian Medical PG Question 8: Beta2-agonists cause all except:
- A. Hyperkalemia (Correct Answer)
- B. Hyperglycemia
- C. Tremor
- D. Palpitation
Drug-Disease Interactions Explanation: ***Hyperkalemia***
- Beta2-agonists actually cause **hypokalemia**, not hyperkalemia, by promoting the intracellular shift of potassium.
- This effect is due to the stimulation of the **Na+/K+-ATPase pump** by beta-2 adrenergic receptors.
*Hyperglycemia*
- Beta2-agonists can lead to **hyperglycemia** by promoting glycogenolysis and gluconeogenesis in the liver.
- They also decrease **insulin secretion** and increase insulin resistance.
*Tremor*
- **Tremor** is a common side effect of beta2-agonists, particularly in the hands, due to direct stimulation of beta2 receptors on skeletal muscle.
- This muscle stimulation leads to increased muscle twitching and a fine tremor.
*Palpitation*
- **Palpitations** can occur due to the systemic absorption of beta2-agonists, leading to activation of beta1 receptors in the heart.
- This can cause **tachycardia** and a sensation of a racing heart.
Drug-Disease Interactions Indian Medical PG Question 9: Which of the following is not an adverse effect of chronic amiodarone therapy?
- A. Hypothyroidism
- B. Pulmonary Fibrosis
- C. Systemic lupus erythematosus (Correct Answer)
- D. Hyperthyroidism
Drug-Disease Interactions Explanation: ***Systemic lupus erythematosus***
- Amiodarone is not typically associated with inducing or exacerbating **systemic lupus erythematosus** (SLE).
- SLE is an **autoimmune disease** with a distinct set of symptoms and serological markers, rarely linked to amiodarone.
*Pulmonary Fibrosis*
- **Pulmonary fibrosis** is a well-known, potentially severe adverse effect of chronic amiodarone therapy, occurring due to drug accumulation in lung tissue.
- Patients may present with **dyspnea, cough**, and diffuse interstitial infiltrates on chest imaging.
*Hypothyroidism*
- Amiodarone contains **iodine**, and its metabolites can inhibit thyroid hormone synthesis and release, leading to **hypothyroidism**.
- This is a common endocrine side effect, often requiring **thyroid hormone replacement**.
*Hyperthyroidism*
- Amiodarone can also cause **hyperthyroidism** through two main mechanisms: an iodine-induced type (Type 1) or a destructive thyroiditis (Type 2).
- Both types lead to excessive thyroid hormone levels and distinct clinical presentations.
Drug-Disease Interactions Indian Medical PG Question 10: A 65-year-old woman with Parkinson’s disease has been experiencing worsening tremors despite taking levodopa. Which medication can be added to her treatment regimen?
- A. Phenytoin
- B. Aspirin
- C. Ropinirole (Correct Answer)
- D. Gabapentin
Drug-Disease Interactions Explanation: ***Ropinirole***
- **Ropinirole** is a **dopamine agonist** that directly stimulates dopamine receptors (D2 and D3) in the brain, mimicking the effects of dopamine. It is commonly used as an **adjunct to levodopa** to improve motor symptoms and reduce off-time in Parkinson's disease.
- When levodopa alone is insufficient to control symptoms (as in this case), dopamine agonists like ropinirole can help to prolong the therapeutic effects and manage **motor fluctuations**, including tremors, by providing more continuous dopaminergic stimulation.
- Ropinirole is FDA-approved for both **monotherapy** in early Parkinson's and as **add-on therapy** in advanced disease with motor complications.
*Phenytoin*
- **Phenytoin** is an **antieconvulsant** medication primarily used to treat epilepsy and certain types of seizures.
- It has **no established role** in the treatment of Parkinson's disease or its associated tremors.
*Aspirin*
- **Aspirin** is an **NSAID** and antiplatelet agent, commonly used for pain relief, fever reduction, and cardiovascular protection.
- It does **not have direct therapeutic effects** on the motor symptoms of Parkinson's disease like tremors.
*Gabapentin*
- **Gabapentin** is an anticonvulsant and neuropathic pain medication, often used to treat **neuropathic pain**, restless legs syndrome, and seizures.
- It is **not effective** for managing the tremors or other motor symptoms of Parkinson's disease.
More Drug-Disease Interactions Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
